Organ Donation & Transplant Matters Resources
6.4K views | +0 today
Follow
Organ Donation & Transplant Matters Resources
Combining reports, research findings and topic reviews
Curated by Deborah Verran
Your new post is loading...
Your new post is loading...
Scooped by Deborah Verran
Scoop.it!

New organ preservation technique could replace cold static storage for donated organs

New organ preservation technique could replace cold static storage for donated organs | Organ Donation & Transplant Matters Resources | Scoop.it

For decades, surgeons around the United States have preserved organs in a cold solution as the organs are shipped in coolers to transplant recipients hundreds of miles away.

 

However the development of machine preservation technology is now allowing trials to be undertaken in order to explore whether there are benefits to preserving donated organs differently.

 

However as this article explores although there may be some benefits to machine preservation of donor organs this comes at a cost and it remains to be seen whether the method will be suitable for all donated organs.

Deborah Verran's insight:

Further data is awaited from the ongoing trials of machine preservation of donated hearts, livers and lungs

more...
No comment yet.
Scooped by Deborah Verran
Scoop.it!

US FDA approves XVIVO lung preservation device

US FDA approves XVIVO lung preservation device | Organ Donation & Transplant Matters Resources | Scoop.it

The U.S. Food and Drug Administration has approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for transplantation.

 

The XVIVO XPS lung perfusion system is one of several devices currently being trialed around the world. It is now hoped that with the judicious use of this type of technology that more donor lungs will be deemed suitable for transplantation. Once this technology becomes more widely available it is anticipated that this should lead to an increase in the numbers of lung transplants over the next 2-5 years.

more...
No comment yet.
Scooped by Deborah Verran
Scoop.it!

Drugs produce high hepatitis C eradication rates, even in patients with liver disease

Drugs produce high hepatitis C eradication rates, even in patients with liver disease | Organ Donation & Transplant Matters Resources | Scoop.it

This is the latest report of success being achieved with new direct anti-viral drugs in the treatment of hepatitis C.

 

Two clinical trials of antiviral drug combinations report that 12-week courses are leading to effective viral eradication for a high percentage of patients with chronic hepatitis C infection.

 

To read more on the particular drugs involved and what the exact results were please click on the banner headline.

Deborah Verran's insight:

Further evidence of the efficacy of some of the new antiviral agents for treating chronic hepatitis C. It is hoped that eventually there will be less patients requiring liver transplantation for liver disease due to this particular virus.

more...
No comment yet.
Rescooped by Deborah Verran from don d'organes : pour sauver des vies, il faut l'avoir dit !
Scoop.it!

Pour la première fois, un coeur artificiel a été greffé à un homme - Le Nouvel Observateur

Pour la première fois, un coeur artificiel a été greffé à un homme - Le Nouvel Observateur | Organ Donation & Transplant Matters Resources | Scoop.it
Le Nouvel Observateur
Pour la première fois, un coeur artificiel a été greffé à un homme
Le Nouvel Observateur
Le patient n'était pas éligible à une greffe en raison de son âge avancé.

 

For another report in Engish click on this link-

http://www.eteknix.com/artificial-heart-offers-hope-transplant-list/

 


Via nathalie Bissot-Campos
Deborah Verran's insight:

For the first time an artificial heart has been transplanted into an adult male in France. Although the article is in French it can be translated into English via Google translate. The short accompanying video provides a glimpse of the actual device

more...
No comment yet.